Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
UltrasisLSE:ULT Equity-to-Asset is 0.11 as of Jul. 2014, which is 86% below its 10-year median of 0.81. The stock has 2 warning signs investors should review.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Ultrasis's Total Stockholders Equity for the quarter that ended in Jul. 2014 was £0.42 Mil. Ultrasis's Total Assets for the quarter that ended in Jul. 2014 was £3.74 Mil.
Therefore, Ultrasis's Equity to Asset Ratio for the quarter that ended in Jul. 2014 was 0.11.
The historical rank and industry rank for Ultrasis's Equity-to-Asset or its related term are showing as below:
LSE:ULT'
s Equity-to-Asset Range Over the Past 10 Years
Min: -2.32 Med: 0.81 Max: 0.91
Current: 0.31
During the past 13 years, the highest Equity to Asset Ratio of Ultrasis was 0.91. The lowest was -2.32. And the median was 0.81.
LSE:ULT's Equity-to-Asset is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 0.48
vs LSE:ULT: 0.31
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Ultrasis Equity-to-Asset Related Terms
Ultrasis Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Ultrasis's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Ultrasis's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ultrasis Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ultrasis's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Ultrasis's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Ultrasis's Equity to Asset Ratio for the fiscal year that ended in Jul. 2014 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ultrasis (LSE:ULT) has a Equity-to-Asset of 0.11 as of Jul. 2014. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Ultrasis and its competitors. This is 86% below median its historical median of 0.81.
Is Ultrasis' Equity-to-Asset too high?
Ultrasis' current Equity-to-Asset of 0.11 is 86% below median its 10-year median of 0.81. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. Ultrasis' value of 0.11 is 77.1% below this industry median.
How does Ultrasis' Equity-to-Asset compare to competitors?
Ultrasis' Equity-to-Asset of 0.11 can be compared against companies in the Healthcare Providers & Services industry. The industry median Equity-to-Asset is 0.48. Ultrasis' value of 0.11 is 77.1% below this benchmark. While the company's 10-year median is 0.81 vs. the industry median of 0.48, Ultrasis has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ultrasis's current Equity-to-Asset of 0.11 is 77.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Ultrasis and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ultrasis's current Equity-to-Asset is 0.11, which is 86% below median its own 10-year median of 0.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ultrasis stock overvalued right now?
Ultrasis (LSE:ULT) has a current Equity-to-Asset of 0.11. The current Equity-to-Asset is 0.11, which is 86% below median its 10-year median of 0.81 and 77.1% below the Healthcare Providers & Services industry median of 0.48. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Ultrasis (LSE:ULT), the current Equity-to-Asset is 0.11 as of Jul. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ultrasis PLC was incorporated in November 23, 1981. The Company through its subsidiary provides healthcare products and services provided via the medium of technology or face to face, that help people maintain, regain and improve their physical, psychological and social well-being. Its product includes Beating the Blues(r), GetFit Wellness, My Brain Solutions, The Relief Series, Drink & Drug Wise, Calm Workplace, and Optimise Me, Screenetics and Joggle.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:ULT has been successfully added to your 
